Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
9th International Conference on Alzheimer's Disease
 and Related Disorders

Updated 14 June 2005

This conference took place in Philadelphia, Pennsylvania, USA, on 17 - 22 July, 2004. Listen to the speakers and view their presentations by clicking on the links below. See related news related to the conference. Download Free Quicktime Player.

Presentations

Lenore Launer: Epidemiology of Alzheimer's Disease: Lessons from Cardiovascular Studies
Dementia is the most common form of neurologic disease in the elderly; Alzheimer's disease (AD) comprises approximately 65% of cases. Epidemiologic studies are designed to measure rates of, etiologic factors for, and progression of dementia. Information from epidemiologic studies provides a means to validate etiologic factors investigated in laboratory research, and can also generate hypotheses to be tested...Click here for more

Laura Fratiglioni: Psychosocial Risk Factors
A psychosocial factor may be defined as a measurement that potentially relates psychological phenomenon to the social environment and to physical changes. The psychosocial component of dementia and cognitive disturbances is a rapidly developing field, but the research evidence is still scarce. Psychosocial factors that have been related to dementia and AD are: personality, life events, work-life stress, leisure activity, social network and socio-economical status.... Click here for more.

M. Flint Beal: Oxidative Mechanisms, Inflammation, and Alzheimer's Disease Pathogenesis
There is a large body of evidence implicating oxidative damage in the pathogenesis of Alzheimer's disease. We previously identified increased concentration of 8-hydroxy-2-deoxyguanosine in both nuclear and mitochondrial DNA of Alzheimer's disease patients. We found a three-fold increase in the amount of oxidative damage to mitochondrial DNA as compared to age-matched controls. Click here for more.

Domenico Pratico: Biomarkers of Alzheimer's disease: F2-isoprostanes
AD is the most common, complex, and challenging neurodegenerative disease associated with dementia in the elderly. Besides the pathological hallmarks of the disease, which include senile plaques and neurofibrillary tangles, AD brain exhibits evidence of reactive oxygen species (ROS)-mediated damage. Click here for more.

Lindsey Farrer: Using a Genetic Approach to Understand the Vascular Basis of Alzheimer Disease
There is a growing body of evidence from pathological and epidemiological studies that risk factors for vascular disease also enhance risk of AD. Objectives: To evaluate the association between genes involved in vascular function and susceptibility to AD in Caucasian and African American families in the MIRAGE Study and in Wadi Ara, an inbred Israeli-Arab community with a high prevalence of AD. Click here for more.

William Mobley: Trafficking the Target-Derived Signals of Neurotrophic Factors: Implications for Normal and Degenerating Neuronse
Elucidating the cellular mechanisms that build and maintain synaptic connections is required for understanding normal and abnormal nervous system function. The neurotrophins (NTs) are a family of neurotrophic factors that act to influence the development and maintenance of neurons. Understanding their physiological roles requires that we elucidate how NT signals generated in the target of innervation are moved retrogradely to cell bodies to regulate cytosolic and nuclear events. Click here for more.

News Reports

Go to Virtual Conferences Main Page



Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad